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Objective
Central statistical monitoring (CSM) can identify trial
misconduct, and help to prioritise on-site visits and
additional training. Key risk indicators (KRIs) focus
CSM on variables most likely to affect study reliability
or patient safety. We developed the use of robust mini-
mum covariance determinant (MCD) distances to detect
outlying centres in the context of KRI analyses.
Method
Initially, a summary statistic (e.g. mean) describing the
KRI is calculated for each centre and robust MCD-based
distances are calculated by the FAST-MCD algorithm
(Rousseeuw, 1999). For each KRI, robust estimates of the
multivariate location P˘R  and scatter ¦˘ R are defined
by minimizing the determinant of the covariance matrix
and generalized distances, D T R
2 1  ( ˘ ) ˘ ( ˘ )x xP ¦ PR R ,
are calculated. The distances follow a Fn2 distribution
(where n is the multivariate dimension) and define corre-
sponding p-values. Outliers are defined as centres with
p-values below a pre-defined threshold (e.g. p<0.05). This
method can be used for univariate and multivariate KRIs.
Furthermore, p-values can be combined across KRIs to
form a single score. We provide empirical examples and
graphical displays of univariate and multivariate KRI ana-
lyses undertaken using this robust MCD distance
approach based on a large-scale multicentre cardiovascu-
lar trial.
Conclusion
Robust MCD distances offer a flexible approach for ana-
lysing both univariate and multivariate KRIs and can be
implemented in standard statistical software.
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